Amitriptyline: Effective Relief for Chronic Pain and Depression
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.46 | $41.06 (0%) | 🛒 Add to cart |
| 120 | $0.41 | $54.75 $49.07 (10%) | 🛒 Add to cart |
| 180 | $0.37 | $82.12 $66.09 (20%) | 🛒 Add to cart |
| 270 | $0.34 | $123.18 $91.13 (26%) | 🛒 Add to cart |
| 360 | $0.32
Best per pill | $164.24 $114.16 (30%) | 🛒 Add to cart |
Synonyms | |||
Amitriptyline is a tricyclic antidepressant (TCA) with a well-established history in managing major depressive disorder and various chronic pain conditions. Its dual-action mechanism modulates neurotransmitters in the central nervous system, offering both mood stabilization and analgesic benefits. Prescribed for decades, it remains a trusted option in clinical practice due to its efficacy, especially in treatment-resistant cases and neuropathic pain syndromes. This medication requires careful patient selection and monitoring to maximize therapeutic outcomes while minimizing risks.
Features
- Active ingredient: Amitriptyline hydrochloride
- Drug class: Tricyclic antidepressant (TCA)
- Available forms: Oral tablets (10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg)
- Mechanism of action: Serotonin and norepinephrine reuptake inhibition; also exhibits anticholinergic, antihistaminic, and alpha-1 adrenergic blocking properties
- Bioavailability: Approximately 30–60% following oral administration
- Half-life: 10–28 hours; active metabolite nortriptyline has a half-life of 18–44 hours
- Excretion: Primarily hepatic metabolism via CYP2D6 and CYP2C19; renal elimination
Benefits
- Provides significant relief from symptoms of major depressive disorder, including low mood, anhedonia, and sleep disturbances.
- Effective in managing neuropathic pain conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia.
- Helps reduce the frequency and severity of chronic tension-type headaches and migraine prophylaxis.
- Can improve sleep architecture due to its sedative properties, particularly beneficial for patients with comorbid insomnia.
- Often effective in cases where SSRIs or other first-line antidepressants have failed.
- May be used off-label for conditions like irritable bowel syndrome (IBS) and interstitial cystitis.
Common use
Amitriptyline is FDA-approved for the treatment of major depressive disorder. It is also widely used off-label for chronic pain management, including neuropathic pain, fibromyalgia, migraine prophylaxis, and tension-type headaches. In psychiatric practice, it may be indicated for anxiety disorders, bulimia nervosa, and as an adjunct in schizophrenia. Its use in low doses for pain or sleep disorders is common, even in the absence of depression.
Dosage and direction
Dosage must be individualized based on indication, patient response, and tolerability. For depression, initial dose is typically 25–50 mg orally at bedtime, titrated upward by 25 mg every 3–7 days as tolerated. Maintenance dose ranges from 50–150 mg daily; maximum dose is 300 mg/day in divided doses. For neuropathic pain or migraine prophylaxis, lower doses (10–75 mg daily) are often effective. Administration at bedtime is recommended to minimize daytime sedation. Elderly patients and those with hepatic impairment require lower initial doses and slower titration. Do not crush, chew, or split tablets; swallow whole with water.
Precautions
Use with caution in patients with cardiovascular disease, due to risk of orthostatic hypotension, tachycardia, and QTc prolongation. Monitor for emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, or mania. May impair mental or physical abilities required for hazardous tasks. Avoid abrupt discontinuation to prevent withdrawal symptoms. Not recommended during pregnancy unless potential benefit justifies potential risk; use in third trimester may lead to neonatal complications. Excreted in breast milk; weigh benefits against risks during lactation. Screen for bipolar disorder prior to initiation.
Contraindications
Hypersensitivity to amitriptyline or other TCAs. Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation. During acute recovery phase after myocardial infarction. Untreated narrow-angle glaucoma. Severe urinary retention.
Possible side effect
Common: Dry mouth, drowsiness, dizziness, constipation, blurred vision, weight gain, orthostatic hypotension.
Less common: Urinary retention, increased intraocular pressure, tachycardia, ECG changes, confusion (especially in elderly), sweating, tremor.
Rare: Seizures, agranulocytosis, jaundice, neuroleptic malignant syndrome (NMS)-like events, serotonin syndrome (especially with other serotonergic drugs).
Psychological: Suicidal ideation or behavior (particularly in young adults), mood worsening.
Drug interaction
MAOIs: Risk of serotonin syndrome, hyperpyrexia, rigidity, myoclonus.
SSRIs/SNRIs/tramadol: Increased serotonergic effects.
CNS depressants (alcohol, benzodiazepines, opioids): Additive sedation and respiratory depression.
Anticholinergics: Enhanced anticholinergic effects.
CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): Increased amitriptyline levels.
Antihypertensives: Potentiated hypotension.
Sympathomimetics: Increased pressor effects.
Warfarin: Altered anticoagulant effect.
Missed dose
If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose. Do not double the dose to make up for a missed one. If regular dosing is interrupted, contact a healthcare provider for guidance to avoid withdrawal symptoms or recurrence of underlying condition.
Overdose
Symptoms: Severe drowsiness, agitation, confusion, hallucinations, tachycardia, hypotension, hyperthermia, dilated pupils, seizures, coma, cardiac arrhythmias, respiratory depression.
Management: Immediate medical attention required. Gastric lavage or activated charcoal if presented early. Supportive care including ECG monitoring, airway management, benzodiazepines for seizures. Sodium bicarbonate for QRS widening. Avoid physostigmine.
Storage
Store at room temperature (15–30°C or 59–86°F) in a tight, light-resistant container. Keep out of reach of children and pets. Do not use after expiration date. Dispose of unused medication via take-back programs or according to local guidelines; do not flush.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual response to amitriptyline may vary. Not all uses discussed may be approved in your region.
Reviews
Clinical studies and meta-analyses consistently support the efficacy of amitriptyline in depression and neuropathic pain, though side effects may limit tolerability for some patients. Many clinicians value its versatility and cost-effectiveness. Patient experiences vary; some report life-changing improvement in mood or pain, while others discontinue due to adverse effects. Long-term use requires periodic reevaluation of benefits versus risks.